APEX1 and non-small cell lung carcinoma: Furthermore, a considerable number of studies together showed that APE1 directly regulated the expression of IL-6 and IL-8 through its redox function [32–34], which also may contribute to the inhibitory immune microenvironment and lead to unfavorable prognosis in NSCLC patients.